Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.38 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5700914 | 1.00 | CYP17A1 (0.47) | CYP17A1PPARGPPARAPSMB8MAPK14 | |
| SCHEMBL4027147 | 0.83 | CYP17A1 (0.46) | CYP17A1PPARGPPARAPSMB8MAPK14 | |
| SCHEMBL5700944 | 0.83 | CYP17A1 (0.46) | CYP17A1PPARGPPARAPSMB8MAPK14 | |
| SCHEMBL4036734 | 0.82 | L3MBTL1 (0.41) | CYP17A1CA1 | |
| SCHEMBL4030166 | 0.82 | L3MBTL1 (0.41) | CYP17A1CA1 | |
| SCHEMBL13055402 | 0.76 | CYP17A1 (0.59) | CYP17A1PSMB8MAPK14NAMPTPTPN11 | |
| SCHEMBL4030831 | 0.76 | CYP17A1 (0.46) | CYP17A1PPARGPPARAPSMB8MAPK14 | |
| SCHEMBL24440386 | 0.76 | PPARG (0.43) | PPARGPPARA | |
| SCHEMBL13118106 | 0.76 | CTSS (0.44) | PPARA | |
| SCHEMBL7334591 | 0.76 | CTSS (0.44) | PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1027328-B1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LTD (GB) | 2006-08-23 | — | — | EP | disclosed |
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| EP-1027328-A1 | SUBSTITUTED ANILIDES | Aventis Pharma Limited (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999023063-A1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LIMITED (GB) | 1999-05-14 | — | — | WO | disclosed |